BioCentury
ARTICLE | Company News

Arius, Roche deal

September 29, 2008 7:00 AM UTC

Roche completed its previously announced acquisition of antibody platform company Arius for about C$191 million (US$182.3 million) in cash (see BioCentury, July 28). ...